HIV/AIDS Prevention

Substitution treatment helps prevent spread of HIV among high-risk group

Published in TB and Outbreaks Week, November 9th, 2004

Injecting drug users are particularly vulnerable to HIV and other blood-borne pathogens as a result of both shared injecting devices and sexual behavior.

Between 5% and 10% of global HIV infections result from use of injected drugs. Oral substitution treatment for opioid users is documented as reducing the incidence of illicit drug use among this population; however, it is unclear what effect this type of treatment has on HIV risk behaviors and the transmission of HIV.

A recent Cochrane Library review of 28 studies involving nearly 8000 participants evaluated the effects of oral substitution treatment on behaviors of drug users with a high risk for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2004-11-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry